-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 NtoEeyvSb/N6rFnHO/s0pfARSKEB5ybuGcuZHNoaYZHsIzUB21cbVJ5c4rykBugI
 sSkIB/i60dgkSGK8t6h4iA==

<SEC-DOCUMENT>0001169232-03-004467.txt : 20030703
<SEC-HEADER>0001169232-03-004467.hdr.sgml : 20030703
<ACCEPTANCE-DATETIME>20030703105519
ACCESSION NUMBER:		0001169232-03-004467
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20030702
ITEM INFORMATION:		Other events
FILED AS OF DATE:		20030703

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MILESTONE SCIENTIFIC INC/NJ
		CENTRAL INDEX KEY:			0000855683
		STANDARD INDUSTRIAL CLASSIFICATION:	ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
		IRS NUMBER:				133545623
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-14053
		FILM NUMBER:		03774027

	BUSINESS ADDRESS:	
		STREET 1:		220 S ORANGE AVE
		STREET 2:		LIVINGSTON CORPORATE PARK
		CITY:			LIVINGSTON
		STATE:			NJ
		ZIP:			07039
		BUSINESS PHONE:		2013793171

	MAIL ADDRESS:	
		STREET 1:		44 KEAN ROAD
		STREET 2:		220 SOUTH ORANGE AVE
		CITY:			LIVINGSTON
		STATE:			NJ
		ZIP:			07039

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	U S OPPORTUNITY SEARCH INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d56215_8-k.txt
<DESCRIPTION>FORM 8-K
<TEXT>

================================================================================

                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   ----------

                                    FORM 8-K

                                 CURRENT REPORT
                     PURSUANT TO SECTION 13 OR 15(d) OF THE
                         SECURITIES EXCHANGE ACT OF 1934

          Date of Report (Date of earliest event reported) July 2, 2003

                            MILESTONE SCIENTIFIC INC.
             (Exact name of Registrant as specified in its charter)

                            Milestone Scientific Inc.
                 (Name of Small Business Issuer in its Charter)

          Delaware                    ____________               13-3545623
(State or other jurisdiction          (Commission              (IRS Employer
     of incorporation)                File Number)           Identification No.)

    220 South Orange Avenue, Livingston Corporate Park, Livingston, NJ 07039
               (Address of Principal Executive Office) (Zip Code)

                  Registrant's telephone number (973) 535-2717

- --------------------------------------------------------------------------------
              (Former name or former address, if changed since last
                                     report)

Item 5: Other Events and Required FD Disclosure

      On July 2, 2003, the Registrant issued a press release announcing the
results of its Annual Meeting of Stockholders and its adjournment Sine Die. A
copy of the Registrant's press release is attached as Exhibit 99.1 to this
Current Report.

<PAGE>

                                   SIGNATURES

      Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this Current Report on Form 8-K to be signed on its
behalf by the undersigned, hereunto duly authorized.

                                      Milestone Scientific Inc.


                                      by: /s/ Leonard Osser
                                          --------------------------------------
                                          Leonard Osser, Chief Executive Officer

Dated: July 2, 2003


                                                                               1


</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>d56215_ex99-1.txt
<DESCRIPTION>PRESS RELEASE
<TEXT>

                                                                    Exhibit 99.1

                                [LOGO] MILESTONE
                                          SCIENTIFIC

                                               FOR IMMEDIATE RELEASE

CONTACT

Stuart J. Wildhorn - Senior Vice President
Milestone Scientific Inc.
(973) 535-2717; (973) 535-2829 (Fax)
Web site: www.milesci.com

           MILESTONE SCIENTIFIC INC. ANNOUNCES ANNUAL MEETING RESULTS;
                              ADJOURNMENT SINE DIE

LIVINGSTON, N.J., July 2, 2003 -- Milestone Scientific Inc. (AMEX: MS) today
announced that at its Annual Meeting of Stockholders held this morning all
nominees for director had been elected and that the Amendment to its Certificate
of Incorporation increasing its authorized shares of Common Stock from 25,000,00
to 50,000,000 had been adopted. While the proposed amendment adding a new class
of preferred stock received overwhelming support from those stockholders voting
on the proposal, the total vote was not sufficient to adopt the proposal.
Accordingly, to allow stockholders the further opportunity to cast their vote on
the proposal the meeting was adjourned sine die.

                                   ----------

Milestone Scientific is the developer, manufacturer and marketer of CompuMed(R)
and CompuDent(R) computer controlled local anesthetic delivery systems. These
systems comprise a microprocessor controlled drive unit as well as The Wand(R)
handpiece, a single patient use product that is held in a pen like manner for
injections. In 2001, Milestone Scientific received broad United States patent
protection on "CompuFlo(TM)", an enabling technology for computer controlled,
pressure sensitive infusion, perfusion, suffusion and aspiration, which provides
real time displays of pressures, fluid densities and flow rates, that advances
the delivery and removal of a wide array of fluids. In 2002, Milestone
Scientific received United States patent protection on a safety engineered
sharps technology, which allows for fully automated true single-handed
activation with needle anti-deflection and force-reduction capability.

This release contains "forward looking statements" based on current expectations
but involving known and unknown risks and uncertainties. Actual results or
achievements may be materially different from those expressed or implied. The
Company's plans and objectives are based on assumptions involving judgments with
respect to future economic, competitive and market conditions, and future
business decisions, all of which are difficult or impossible to predict
accurately and many of which are beyond the control of the Company. Therefore,
there can be no assurance that the forward-looking statements, including, but
not limited to, those relating to the availability of capital pursuant to this
facility, will prove to be accurate.

      Contact: Milestone Scientific Inc.
               Stuart J. Wildhorn, 973/535-2717
               Fax: 973/535- 2829
               www.milesci.com

                                       ###

</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
